GlassScriptPhysician profile
Ali Ziaee
NPI 1184689549
$5,040.70
in general payments reported to CMS, 2019-2025
20 companies · $1,244 in 2025
The $1,244 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $131 · 2021: $443 · 2022: $1,060 · 2023: $884 · 2024: $1,111 · 2025: $1,244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,239.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,171.53 | 2021-2025 | Impella |
| Abbott Laboratories | $809.71 | 2020-2025 | Amplatzer Amulet, Amplatzer Talisman, Confirm Rx |
| Edwards Lifesciences Corporation | $701.01 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $486.47 | 2020-2025 | Lifevest |
| Philips North America LLC | $336.17 | 2022-2023 | |
| Cvrx, INC. | $321.33 | 2022-2025 | Barostim Neo System |
| Medtronic, INC. | $268.96 | 2023-2025 | Symplicity G3, Onyx Frontier, Micra |
| Pfizer INC. | $217.84 | 2023-2025 | |
| Amgen INC. | $161.84 | 2019-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $126.85 | 2020-2025 | Eliquis |
| Shockwave Medical, INC | $105.75 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $83.11 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $60.44 | 2022-2024 | Brilinta, Farxiga |
| Terumo Medical Corporation | $52.70 | 2025 | Tr Band, Angio-Seal |
| Medtronic Vascular, INC. | $46.52 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $22.36 | 2020 | |
| Inspire Medical Systems, INC. | $21.11 | 2023 | Inspire |
| Novartis Pharmaceuticals Corporation | $17.42 | 2022 | |
| Kestra Medical Technology Services, INC. | $16.04 | 2023 | Assure Wcd |
| Cardiovascular Systems INC. | $13.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Ziaee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.